Title : Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.

Pub. Date : 2017 Dec 1

PMID : 29196725






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To investigate the role of polymorphisms in nAChR genes on smoking quantity and the outcome of smoking-cessation therapies, we carried out an association study on 337 smokers who underwent pharmacotherapy with varenicline, bupropion, nicotine replacement therapy (NRT) alone, or NRT plus bupropion. Bupropion cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
2 To investigate the role of polymorphisms in nAChR genes on smoking quantity and the outcome of smoking-cessation therapies, we carried out an association study on 337 smokers who underwent pharmacotherapy with varenicline, bupropion, nicotine replacement therapy (NRT) alone, or NRT plus bupropion. Bupropion cholinergic receptor nicotinic alpha 4 subunit Homo sapiens